NeuroTech Solutions Overview
- Founded
- 1999
- Status
- Private
- Employees
- 14
- Latest Deal Type
- Grant
- Latest Deal Amount
- $55.5K
- Investors
- 4
NeuroTech Solutions General Information
Description
Developer of a medical condition screening and diagnostic platform designed to offer diagnosis of attention deficit hyperactivity disorder (ADHD). The company's platform focuses on human cognition and behavior and offers real-time evaluation of ADHD through web-based tests and evaluates a patient's attentive profile, enabling children and adults to develop their self-esteem and confidence and improve their lives.
Contact Information
Website
www.neurotech-solutions.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- Haplada 3
- Or Yehuda
- Israel
+972 00-000-0000
NeuroTech Solutions Timeline
NeuroTech Solutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 31-Jan-2020 | $55.5K | 00.00 | Completed | Generating Revenue | |
| 4. Secondary Transaction - Private | 23-Jan-2019 | 00.00 | Completed | Generating Revenue | ||
| 3. Later Stage VC | 31-Jan-2018 | 00.00 | Completed | Generating Revenue | ||
| 2. Later Stage VC | 01-Jan-2012 | $2M | $2.2M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jan-2007 | $200K | $200K | Completed | Startup |
NeuroTech Solutions Patents
NeuroTech Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20100178640-A1 | Computerized test apparatus and methods for quantifying psychological aspects of human responses to stimuli | Abandoned | 12-Jan-2009 | 000000000 | 0 |
| JP-5676112-B2 | Method for measuring the effects of distraction, computerized test system, system for measuring the effects of distraction, method for measuring the behavior of human subjects, and for measuring the effects of stimuli system | Active | 12-Jan-2009 | 000000000 | |
| JP-2010158523-A | Method for measuring effect of distraction, computerized test system, system for measuring effect of distraction, method for measuring action of human subject, and system for measuring effect of stimuli | Granted | 12-Jan-2009 | 000000000 | |
| EP-2206464-A1 | Computerized test apparatus and methods for quantifying psychological aspects of human responses to stimuli | Withdrawn | 12-Jan-2009 | A61B5/168 | 0 |
NeuroTech Solutions Executive Team (10)
NeuroTech Solutions Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Yoav Ben-Dror | Impact First Investments | Chairman | 000 0000 |
NeuroTech Solutions Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNeuroTech Solutions Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 | ||
| Guangzhou-Israel Biomedical Fund | Other | Minority | 000 0000 | 000000 0 | |
| De Hoge Dennen Capital | Family Office | Minority | 000 0000 | 000000 0 | |
| Noaber | Impact Investing | Minority | 000 0000 | 000000 0 |